20/04/2026
⚠️ Product Correction - Flixotide and Pavtide Accuhalers⚠️
GlaxoSmithKline (GSK) Australia Pty Ltd is issuing a product correction for certain batches of their Flixotide and Pavtide Accuhalers as a small number of Accuhalers may not automatically reload the next dose.
The Accuhaler will function normally for several doses (anywhere between 20-59 doses) and may then stop working.
If the dose is not manually reset, this may lead to a short-term flare-up of asthma symptoms.
In the unlikely event you have an impacted device (where the lever is in the incorrect starting position) do not stop using your Accuhaler.
Visit our website to see the affected product names, batch numbers and expiry date, as well as what you should do to correct the problem: https://www.tga.gov.au/safety/recalls-and-other-market-actions/market-actions/flixotide-and-pavtide-accuhalers